Viewing StudyNCT00003532



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003532
Status: TERMINATED
Last Update Posted: 2017-12-12
First Post: 1999-11-01

Brief Title: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Sponsor: Burzynski Research Institute
Organization: Burzynski Research Institute

Conditions & Keywords Data

Conditions:
Name
Stage IV Ovarian Cancer
Stage III Ovarian Cancer
Keywords:
Name View
Stage III ovarian epithelial cancer View
Stage IV ovarian epithelial cancer View
Stage III ovarian germ cell tumor View
Stage IV ovarian germ cell tumor View